Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer

International Journal of Biological Macromolecules

Volumn 50, Issue 4, 2012, Pages 1127-1132

  Abdalla, Mohamed M ^a   Al Omar, Mohamed A ^b   Bhat, Mashooq A ^b   Amr, Abdel Galil E ^b,c   Al Mohizea, Abdullah M ^b  

^a Saco Pharm Co   (Egypt)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Aromatase inhibitor; Quinone reductase 2 inhibitor; Steroidal pyrazolines

Indexed keywords

AROMATASE INHIBITOR; CYPROTERONE; OXIDOREDUCTASE INHIBITOR; PYRAZOLINE DERIVATIVE; QUINONE REDUCTASE 2 INHIBITOR; RESVERATROL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; HELA CELL; HUMAN; HUMAN CELL; IC 50; LD 50; STRUCTURE ACTIVITY RELATION;

EID: 84860235649     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2012.02.006     Document Type: Article

References (43)

1. Al-Mohizea A.M., Al-Omar M.A., Abdalla M.M., Amr A.E. Int. J. Biol. Macromol. 2012, 50:171-179.
2. Amr E.A., Abdel-Latif N.A., Abdulla M.M. Bioorg. Med. Chem. 2006, 14:373-384.
3. Amr A.E., Hegab M.I., Ibrahiem A.A., Abdulla M.M. Monatsh. Chem. 2003, 134:1395-1409.
4. Abou-Ghalia M.H., Amr A.E. Amino Acids 2004, 26:283-289.
5. Braña M.F., Castellano J.M., Morán M., Pérez de Vega M.J., Qian X.D., Romerdahl C.A., Keilhauer G. Eur. J. Med. Chem. 1995, 30:235-239.
6. Mohamed A.M., Amr A.E., Alsharari M.A., Al-Qalawi H.R.M., Germoush M.O., Al-Omar M.A. Am. J. Biochem. Biotech. 2011, 7:43-54.
7. Amr A.E., Mohamed A.M., Ibrahim A.A. Z. Naturforsch. 2003, 58:861-868.
8. Amr A.E., Abdel-Salam O.I., Attia A., Stibor I. Collect. Czech. Chem. Commun. 1999, 64:288-298.
9. Attia A., Abdel-Salam O.I., Stibor I., Amr A.E., Budesinsky M. Egypt. J. Chem. 2000, 43:187-201.
10. Fahmy H.H., El-Eraqy W. Arch. Pharm. Res. 2001, 24:171-179.
11. Abou-Ghalia M.H., Amr A.E., Abdulla M.M. Z. Naturforsch. 2003, 58b:903-910.
12. Hukki J., Laitinen P., Alberty J.E. Pharm. Acta Helv. 1968, 43:704-712.
13. Jung J.C., Watkins E.B., Avery M.A. Heterocycles 2005, 65:77-94.
14. Bansal E., Srivastava V.K., Kumar A. Eur. J. Med. Chem. 2001, 36:81-92.
15. Bhat A.R., Rao S.N., Udupi R.H. Ind. J. Heterocycl. Chem. 1998, 7:217-220.
16. Ahn J.H., Kim H.M., Jung S.H., Kang S.K., Kim K.R., Rhee S.D., Yang S.D., Cheon H.G., Kim S.S. Bioorg. Med. Chem. Lett. 2004, 14:4461-4465.
17. Villhauer E.B., Brinkman J.A., Naderi G.B., Dunning B.E., Mangold B.L., Mone M.D., Russell M.E., Weldon S.C., Hughes T.E. J. Med. Chem. 2002, 45:2362-2365.
18. Amr A.E. Indian J. Heterocycl. Chem. 2000, 10:49-58.
19. Hammam A.G., Fahmy A.F.M., Amr A.E., Mohamed A.M. Ind. J. Chem. 2003, 42B:1985-1993.
20. Hammam A.G., Abdel Hafez N.A., Midura W.H., Mikolajczyk M. Z. Naturforsch. 2000, 55b:417-424.
21. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. CA Cancer J. Clin. 2008, 58:71-96.
22. Chen S., Zhou D., Okubo T., Kao Y.C., Eng E.T., Grube B., Kwon A., Yang C., Yu B. Ann. N.Y. Acad. Sci. 2002, 963:229-238.
23. Brueggemeier R.W., Richards J.A., Joomprabutra S., Bhat A.S., Whetstone J.L. J. Steroid Biochem. Mol. Biol. 2001, 79:75-84.
24. Banting L., Nicholls P.J., Shaw M.A., Smith H.J. Prog. Med. Chem. 1989, 26:253-298.
25. Lonard D.M., Smith C.L. Steroids 2002, 67:15-24.
26. Park W.C., Jordan V.C. Trends Mol. Med. 2002, 8:82-88.
27. Nicholls H. Trends Mol. Med. 2002, 8:S12-S13.
28. Miller W.R. Best. Pract. Res. Clin Endocrinol. Metab. 2004, 18:1-32.
29. Miller W.R. Semin. Oncol. 2003, 30:3-11.
30. Buzdar A.U. Clin. Breast Cancer. 2003, 4:S84-S88.
31. Recanatini M., Cavalli A., Valenti P. Med. Res. Rev. 2002, 22:282-304.
32. Maiti A., Cuendet M., Croy V.L., Endringer D.C., Pezzuto J.M., Cushman M. J. Med. Chem. 2007, 50:2799-2806.
33. Mokbel K. Int. J. Clin. Oncol. 2002, 7:279-283.
34. Wang Y., Lee K.W., Chan F.L., Chen S., Leung L.K. Toxicol. Sci. 2006, 92:71-77.
35. Maiti A., Reddy P.V., Sturdy M., Marler L., Pegan S.D., Mesecar A.D., Pezzuto J.M., Cushman M. J. Med. Chem. 2009, 52:1873-1884.
36. Celli C.M., Tran N., Knox R., Jaiswal A.K. Biochem. Pharmacol. 2006, 72:366-376.
37. Jamieson D., Tung A.T., Knox R.J., Boddy A.V. Br. J. Cancer 2006, 95:1229-1233.
38. Knox R.J., Jenkins T.C., Hobbs S.M., Chen S., Melton R.G., Burke P.J. Cancer Res. 2000, 60:4179-4186.
39. Buryanovskyy L., Fu Y., Boyd M., Ma Y., Hsieh T.C., Wu J.M., Zhang Z. Biochemistry 2004, 43:11417-11426.
40. Boutin J.A., Audinot V., Ferry G., Delagrange P. Trends Pharmacol. Sci. 2005, 26:412-419.
41. Calamini B., Santarsiero B.D., Boutin J.A., Mesecar A.D. Biochem. J. 2008, 413:81-91.
42. Grever M.R., Schepartz S.A., Chabner B.A. Semin. Oncol. 1992, 19:622-638.
43. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A., et al. J. Natl. Cancer Inst. 1991, 83:757-766.